Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY 4.0PLOS One

HIV and Hepatitis B co-infection in Tanzania: Analysis of the 2022–2023 Tanzania HIV Impact Survey

4 affiliations
  1. 1Department of Community Health, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
  2. 2Department of Epidemiology and Biostatistics, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
  3. 3School of Nursing and Midwifery, Aga Khan University, Dar es Salaam, Tanzania
  4. 4Department of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa

Abstract

Co-occurrence of HIV and Hepatitis B Virus (HBV) in sub-Saharan Africa, although less prevalent, is often more serious and exhibits rapid clinical deterioration even with appropriate treatment, jeopardizing efforts to reach regional and global targets. Evidence varies in the region and not reported in some countries. We used data from the nationally representative survey to characterize the burden and determinants of HIV and HBV co-occurrence in Tanzania. This secondary data analysis of the Tanzania HIV Impact Survey (THIS) involved 33,263 individuals aged 15 years and above, randomly selected from 14,966,262 households from 31 regions of Tanzania. The main outcome variable was HIV and HBV coinfections. Analyses were conducted using descriptive analysis, to estimate prevalence of co-occurrences, while Chi-square test used to characterize the burden. Through bivariable and multivariable binomial logistic regression models, we could estimate the associations between different independent variables with HIV-HBV co-occurrence. The burdens of HIV and HBV in the general population were 4.4% and 3.5% respectively. The prevalence of dual HIV and HBV infections was 0.3%. Among people diagnosed with HIV, 6.2% had HBV co-occurrence. After adjusting for confounder and other variables, age was significantly associated with coinfection (aOR = 1.02; 95% CI: 1.01–1.03; p < 0.001). Participants who were not in union had significantly higher risk of coinfection compared with those in union (aOR = 1.56; 95% CI: 1.01–2.41; p = 0.047). Having one lifetime sexual partner remained strongly protective factor against HIV-HBV coinfection (aOR = 0.19; 95% CI: 0.09–0.42; p < 0.001). Although the burden of HIV/HBV coinfection remains as low as 0.3% in the general population in Tanzania, the risk remains high among older adults and those with multiple sexual partnerships. Integrating HBV screening in all opportunities presented in the successful HIV program may help addressing the dual burden. For effectiveness, more efforts should target people with high-risk sexual behaviors and those with advanced age.

Related

  1. Risky sexual behaviors and associated factors among adolescent girls and young women in the context of HIV prevention pre-exposure prophylaxis in Tanzania: Analysis of the Tanzania HIV Impact Survey 2022–2023
    Magreth Thadei Mwakilasa, Deodatus Kakoko, John Gilmore +1
    PLOS Global Public HealthPeer-reviewedCC BYFull textMicrobiologyEpidemiology & public healthPLOSEurope PMC
  2. Retrospective Serological Survey of Equine Influenza Virus and Piroplasm Parasites in Free-Ranging Wild Equids from Kenya and Tanzania.
    Silvia Marchi, Charles Issel, Paul Kanyari +2
    Veterinary sciencesPeer-reviewedCC BYFull textMicrobiologyEurope PMC
  3. Bacterial urinary tract infections and urogenital schistosomiasis co-infection among primary school children in a Meatu district, Tanzania: A call for an integrated preventive approach
    Johannes Rukyaa, Prisca Damiano, Vitus Silago +4
    PLOS OnePeer-reviewedCC BYFull textMicrobiologyInfectious diseasePLOSEurope PMCPMC
  4. Patterns and determinants of formal healthcare utilisation among individuals with and without proxy-identified mental health need in Tanzania: A cross-sectional analysis of the National Panel Survey
    Gallen Mlenge, Odass Bilame, Lutengano Mwinuka
    PLOS Mental HealthPeer-reviewedCC BY 4.0Full textNeuroscienceNeurologyPLOS
  5. Impact of structured sexual health training incorporating standardised patients on health professions students’ sexual health communication competence: A single-blind randomised controlled trial in Tanzania
    Gift G. Lukumay, Deodatus Kakoko, B. R. Simon Rosser +1
    PLOS OnePeer-reviewedCC BY 4.0Full textNeurosciencePLOS
BibTeX
@article{mwakasungura2026hepatitis,
  title = {{HIV and Hepatitis B co-infection in Tanzania: Analysis of the 2022–2023 Tanzania HIV Impact Survey}},
  author = {Felistar Mwakasungura and Alfateresia Mwasangama and Davis Amani and Elias Bukundi and Bruno Sunguya},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0358242},
  url = {https://doi.org/10.1371/journal.pone.0358242},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - HIV and Hepatitis B co-infection in Tanzania: Analysis of the 2022–2023 Tanzania HIV Impact Survey
AU  - Felistar Mwakasungura
AU  - Alfateresia Mwasangama
AU  - Davis Amani
AU  - Elias Bukundi
AU  - Bruno Sunguya
PY  - 2026
DA  - 2026/09/11
JO  - PLOS One
DO  - 10.1371/journal.pone.0358242
UR  - https://doi.org/10.1371/journal.pone.0358242
AB  - Co-occurrence of HIV and Hepatitis B Virus (HBV) in sub-Saharan Africa, although less prevalent, is often more serious and exhibits rapid clinical deterioration even with appropriate treatment, jeopardizing efforts to reach regional and global targets. Evidence varies in the region and not reported in some countries. We used data from the nationally representative survey to characterize the burden and determinants of HIV and HBV co-occurrence in Tanzania. This secondary data analysis of the Tanzania HIV Impact Survey (THIS) involved 33,263 individuals aged 15 years and above, randomly selected from 14,966,262 households from 31 regions of Tanzania. The main outcome variable was HIV and HBV coinfections. Analyses were conducted using descriptive analysis, to estimate prevalence of co-occurrences, while Chi-square test used to characterize the burden. Through bivariable and multivariable binomial logistic regression models, we could estimate the associations between different independent variables with HIV-HBV co-occurrence. The burdens of HIV and HBV in the general population were 4.4% and 3.5% respectively. The prevalence of dual HIV and HBV infections was 0.3%. Among people diagnosed with HIV, 6.2% had HBV co-occurrence. After adjusting for confounder and other variables, age was significantly associated with coinfection (aOR = 1.02; 95% CI: 1.01–1.03; p < 0.001). Participants who were not in union had significantly higher risk of coinfection compared with those in union (aOR = 1.56; 95% CI: 1.01–2.41; p = 0.047). Having one lifetime sexual partner remained strongly protective factor against HIV-HBV coinfection (aOR = 0.19; 95% CI: 0.09–0.42; p < 0.001). Although the burden of HIV/HBV coinfection remains as low as 0.3% in the general population in Tanzania, the risk remains high among older adults and those with multiple sexual partnerships. Integrating HBV screening in all opportunities presented in the successful HIV program may help addressing the dual burden. For effectiveness, more efforts should target people with high-risk sexual behaviors and those with advanced age.
SN  - 1932-6203
ER  -